Literature DB >> 8825453

Glycoprotein A is the immunodominant antigen of Pneumocystis carinii in mice following immunization.

F Gigliotti1, T McCool.   

Abstract

A rapid and simple dual enzyme-linked immunosorbent assay was developed to quantitate the relative frequency of monoclonal antibodies produced against Pneumocystis carinii glycoprotein A (gpA) or other antigens of P. carinii after immunization with whole organisms. In BALB/cj mice, P. carinii gpA was clearly the immunodominant antigen, with a quarter of all hybridomas secreting antibody directed against this molecule.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8825453     DOI： 10.1007/s004360050075

Source DB:  PubMed          Journal:  Parasitol Res        ISSN： 0932-0113            Impact factor:   2.289


  4 in total

1.  Purification and initial characterization of a ferret Pneumocystis carinii surface antigen.

Authors:  F Gigliotti; L R Ballou; W T Hughes; B D Mosley
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

2.  Development of murine monoclonal antibodies to Pneumocystis carinii.

Authors:  F Gigliotti; D C Stokes; A B Cheatham; D S Davis; W T Hughes
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

3.  Serologic responses to Pneumocystis carinii antigens in health and disease.

Authors:  S L Peglow; A G Smulian; M J Linke; C L Pogue; S Nurre; J Crisler; J Phair; J W Gold; D Armstrong; P D Walzer
Journal:  J Infect Dis       Date:  1990-02       Impact factor: 5.226

4.  Host species-specific antigenic variation of a mannosylated surface glycoprotein of Pneumocystis carinii.

Authors:  F Gigliotti
Journal:  J Infect Dis       Date:  1992-02       Impact factor: 5.226
  4 in total
  9 in total

Review 1.  Genetics of surface antigen expression in Pneumocystis carinii.

Authors:  J R Stringer; S P Keely
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Sensitized CD8+ T cells fail to control organism burden but accelerate the onset of lung injury during Pneumocystis carinii pneumonia.

Authors:  Francis Gigliotti; Elliott L Crow; Samir P Bhagwat; Terry W Wright
Journal:  Infect Immun       Date:  2006-08-28       Impact factor: 3.441

Review 3.  Natural pathogens of laboratory mice, rats, and rabbits and their effects on research.

Authors:  D G Baker
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

Review 4.  Prevention of infection due to Pneumocystis carinii.

Authors:  J A Fishman
Journal:  Antimicrob Agents Chemother       Date:  1998-05       Impact factor: 5.191

5.  B Lymphocytes Are Required during the Early Priming of CD4+ T Cells for Clearance of Pneumocystis Infection in Mice.

Authors:  Michael M Opata; Melissa L Hollifield; Frances E Lund; Troy D Randall; Robert Dunn; Beth A Garvy; David J Feola
Journal:  J Immunol       Date:  2015-06-03       Impact factor: 5.422

6.  Antibody-mediated shift in the profile of glycoprotein A phenotypes observed in a mouse model of Pneumocystis carinii pneumonia.

Authors:  F Gigliotti; B A Garvy; A G Harmsen
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

7.  Epitope mapping of a protective monoclonal antibody against Pneumocystis carinii with shared reactivity to Streptococcus pneumoniae surface antigen PspA.

Authors:  Jesse Wells; Francis Gigliotti; Patricia J Simpson-Haidaris; Constantine G Haidaris
Journal:  Infect Immun       Date:  2004-03       Impact factor: 3.441

8.  Immunization with Pneumocystis carinii gpA is immunogenic but not protective in a mouse model of P. carinii pneumonia.

Authors:  F Gigliotti; J A Wiley; A G Harmsen
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

Review 9.  Pneumocystis Pneumonia: Immunity, Vaccines, and Treatments.

Authors:  Aaron D Gingerich; Karen A Norris; Jarrod J Mousa
Journal:  Pathogens       Date:  2021-02-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.